Study of lung cancer patients who got chemo-immunotherapy before planned surgery but didn't have surgery
Part of Cancer, Lungs & breathing clinical trials.
This study looks at patients with stage II or III non-small cell lung cancer who started chemotherapy plus immunotherapy before planned surgery but did not actually have surgery. It aims to understand why surgery was canceled and how patients did over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage II or III non-small cell lung cancer (based on tests like scans)
- You started chemotherapy plus immunotherapy as a first treatment, intending to have surgery later
- You received at least one cycle of this treatment
- You did not have surgery for at least six months after starting this treatment
- Your doctors have records of why surgery was canceled and how you are doing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving chemotherapy plus immunotherapy before surgery helps people with a specific type of advanced lung cancer. It aims to see if this approach can shrink tumors and make surgery more effective.
This trial is testing a treatment given before surgery for non-small cell lung cancer. Patients receive chemotherapy plus immunotherapy (chemo-immunotherapy) first, then have surgery to remove the tumor. The goal is to see how well this approach works.
This trial tests a combination of chemotherapy and immunotherapy given before surgery for stage II or III non-small cell lung cancer. Doctors will look at biomarkers in your blood and tissue to see how the cancer responds, which could help guide future treatments.
This study looks at how well immunotherapy given before surgery works for non-small cell lung cancer. It aims to help doctors understand real-world outcomes for patients who receive this treatment.
This trial tests combining chemotherapy with immunotherapy before surgery for people with stage III non-small cell lung cancer that has a PD-L1 level of 1% or higher. The goal is to see if this approach can improve outcomes.
This trial tests if receiving immunotherapy before surgery works better than getting it after surgery for people with stage II to IIIB non-small cell lung cancer. The goal is to see which timing helps prevent the cancer from coming back.
Hear when a new Stage II-III Non-small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.